Q2 2018 Holdings
Filed 2018-08-07 | 13 holdings | $35.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Gilead Sciences Inc(GILD) | COM | 375558103 | $7.1K | 100,000 | 20.1% |
| Tyme Technologies Inc | COM | 90238J103 | $6.6K | 2,075,000 | 18.6% |
| Novelion Therapeutics Inc | COM NEW | 67001K202 | $4.8K | 1,313,387 | 13.7% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $4.0K | 100,000 | 11.4% |
| Allergan PLC | SHS | G0177J108 | $3.3K | 20,000 | 9.5% |
| Proshares TR | ULTSH NASD BIOT | 74347B789 | $2.9K | 150,000 | 8.3% |
| Fluidigm Corp del(LAB) | COM | 34385P108 | $2.7K | 450,000 | 7.6% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $1.5K | 500,000 | 4.4% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $1.4K | 150,000 | 4.0% |
| Amarin Corp PLCCall | SPONS ADR NEW | 023111206 | $309 | 100,000 | 0.9% |
| Antares Pharma Inc(ATRSEUR) | COM | 036642106 | $258 | 100,000 | 0.7% |
| Antares Pharma Inc(ATRSEUR)Call | COM | 036642106 | $258 | 100,000 | 0.7% |
| Apricus Biosciences Inc | COM NEW | 03832V307 | $39 | 100,000 | 0.1% |